THUNDEROBOT
872190
Ji Yao Holding Group
300108
Hangzhou Huasu Technology
301157
Flaircomm Microelectronics, Inc.
301600
Jiusheng Electric
301082
CN Stock MarketDetailed Quotes
688428 InnoCare Pharma
- 11.40
- +0.23+2.06%
Market Closed Jan 7 15:00 CST
20.09BMarket Cap-53.52P/E (TTM)
11.42High11.09Low44.98KlotVolume11.22Open11.17Pre Close50.78MTurnover1.69%Turnover RatioLossP/E (Static)1.76BShares15.1552wk High2.95P/B3.04BFloat Cap7.2852wk Low13.40Limit Up266.28MShs Float16.99Historical High8.94Limit Down2.95%Amplitude7.28Historical Low--Dividend TTM11.29Avg Price22.81KlotAsk--Div YieldTTM100Lot Size20.97KlotBid
InnoCare Pharma News
Hong Kong Stock Announcement: Grant of Restricted Share Units under the 2023 Equity Incentive Plan
Nuochengjianhua: Self-inspection report of Nuochengjianhua Pharmaceutical Co., Ltd. on the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan insider information insider\'s stock trading situation
Nuocheng Jianhua: List of incentive recipients granted for the first time in the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan of Nuocheng Jianhua Pharmaceutical Co., Ltd. (as of the date of first award)
Nuocheng Jianhua: Legal Opinion of Shanghai Fangda Law Firm on matters relating to the first grant of the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan by InnoCare Pharma Limited (InnoCare Pharma Limited)
Nuochengjianhua: Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on granting restricted shares to incentive recipients for the first time
Nuochengjianhua: Independent Financial Advisory Report of Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. on the first grant of Nuochengjianhua Pharmaceutical Co., Ltd.\'s 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan
Nuochengjianhua Pharmaceutical Co., Ltd. 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan first award list (as of the date of first award)
Legal opinion from Shanghai Fangda Law Firm on matters relating to the first grant of the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan by InnoCare Pharma Limited (InnoCare Pharma Limited)
Announcement of Nuochengjianhua Pharmaceutical Co., Ltd. on granting restricted shares to incentive recipients for the first time
Nuochengjianhua Pharmaceutical Co., Ltd.\'s self-inspection report on the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan insider information insider\'s stock trading situation
Nuochengjianhua: Explanation of the inspection opinions and publicity of Nuochengjianhua Pharmaceutical Co., Ltd. on the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan for the first time
Explanation of the inspection opinions and publicity of Nuochengjianhua Pharmaceutical Co., Ltd. on the 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan for the first time
Legal Opinion of Shanghai Fangda Law Firm on InnoCare Pharma Limited (InnoCare Pharma Limited) 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan (Draft)
Nuochengjianhua Pharmaceutical Co., Ltd. 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan (Draft) Summary Announcement
Nuochengjianhua Pharmaceutical Co., Ltd. 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan (Draft)
Nuochengjianhua Pharmaceutical Co., Ltd. 2024 Science and Technology Innovation Board Restricted Stock Incentive Plan Incentive List
Announcement on the initial public offering of Nuochengjianhua Pharmaceutical Co., Ltd., the listing and circulation of restricted shares
Innocare Pharmaceutical Co., Ltd.'s Announcement on Changes in Shareholders' Equity of More Than 5%
Innocare Pharmaceuticals Limited Summary of Changes in Equity Report
Innocare Pharmaceutical Co., Ltd. announcement of the first attribution period and stock listing of the 2023 Star Market Restricted Stock Incentive Plan.